Gomez-Ospina Lab

Precise medicines for genetic diseases. Read our recent work in Nature Communications here:

[Gomez-Ospina Lab @GomezOspinaLab]

Bone marrow transplants offer surprising way to treat mitochondrial disease, Stanford Medicine study shows https://t.co/G0yzEbLcOP

[Gomez-Ospina Lab @GomezOspinaLab]

Bone marrow transplants could offer a new way to treat mitochondrial diseases like Friedreich’s ataxia. A @StanfordMed study in @NatComms showed donor immune cells delivered healthy mitochondria to failing heart & brain cells, improving symptoms in mice. https://t.co/jpN00026ga

[Gomez-Ospina Lab @GomezOspinaLab]

Natalia Gomez-Ospina, MD, PhD | News Center https://t.co/mIlQfeUpTy

[ACMG @TheACMG]

ACMG recognizes Natalia Gomez-Ospina, MD, PhD with the 2024 #ACMGFoundation Dr. Michael S. Watson Genetic and Genomic Medicine Innovation Award. She is an Assistant Professor of Pediatrics (Genetics) @StanfordMed. https://t.co/a8di71etPS #ACMGMtg24@CdcmStanford@StanfordChild

[Gomez-Ospina Lab @GomezOspinaLab]

Proud to have participated in such a great panel!

[Sek Kathiresan MD @skathire]

Exceptional @KeystoneSymp on Precision Genome Engineering last week

Speaks to value of *in-person interaction* to learn & stimulate new ideas

Here with A. Kwilas, J. Doudna, N. Gomez-Ospina, & @UrnovFyodor

👏M. Porteus & L. Sepp-Lorenzino for organizing

[Gomez-Ospina Lab @GomezOspinaLab]

Congratulations to all CZI awardees!
https://t.co/FqheyCInjE

[Dr. Nathan A. Smith @NathanASmith1]

What an amazing cohort!!! Congratulations to all the winners. CZI Science Diversity Leadership Award Grantees https://t.co/gYaueWZtGH

[Gomez-Ospina Lab @GomezOspinaLab]

Improved engraftment and therapeutic efficacy by human genome-edited hematopoietic stem cells with Busulfan-based myeloablation https://t.co/Lf6LXWFPsG

[Gomez-Ospina Lab @GomezOspinaLab]

https://t.co/iwgXwEOYud
For women in science. Awards are meant to showcase great accomplishment and also to inspire others to follow in their footsteps.

[Graphite Bio @GraphiteBio]

In honor of #InternationalGaucherDay, Graphite Bio was joined by Dr. Natalia Gomez-Ospina from @GomezOspinaLab at @Stanford. Thank you for sharing about this life-impacting disease and current research approaches with our team. #IGD2021 #EarlyDiagnosis #RareButNotAlone

[Gomez-Ospina Lab @GomezOspinaLab]

Very excited to present our work at #ASGCT21 and thankful for the award. Happy to share the screen with Dr. Hans Peter Kiem @fredhutch

[Gomez-Ospina Lab @GomezOspinaLab]

So proud to have received an outstanding young investigator award #ASGCT21 Award winners!
https://t.co/HLB6MLhe39

[ASGCT @ASGCTherapy]

Natalia Gomez-Ospina (@Stanford), Annarita Miccio (@InstitutImagine), and @jerrymendell1 (@nationwidekids)!

[ASGCT @ASGCTherapy]

Scientists from @UTSWNews successfully employed a new type of #genetherapy to treat mice with #Duchenne #MuscularDystrophy (#DMD), utilizing #CRISPR-Cas9-based tools to restore dystrophin protein that is missing in many DMD patients. https://t.co/DvgzaQNcgf

[Gomez-Ospina Lab @GomezOspinaLab]

https://t.co/zyhqINwm7p

[Gomez-Ospina Lab @GomezOspinaLab]

Should You Bank Your Baby’s Cord Blood? https://t.co/xmd6n5u9Gn

[Gomez-Ospina Lab @GomezOspinaLab]

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia | NEJM https://t.co/353HketVpB

[Gomez-Ospina Lab @GomezOspinaLab]

Ready to test in humans. Very cool

[CDCM-Stanford University @CdcmStanford]

IND Clearance Received for Sickle Cell Disease Gene Editing Clinical Trial. Congratulations to CDCM Co-Director, Matthew Porteus and the team at the CDCM for this great achievement.#sicklecell #cdcm @cirm @graphitebio @stanfordmed Read more about it here: https://t.co/qwpgU8QJAN

[Gomez-Ospina Lab @GomezOspinaLab]

https://t.co/9sJrdzNlTx

[ASGCT @ASGCTherapy]

The first shot of the #mRNA #COVID19 vaccine, approved by the @US_FDA Friday evening, was administered to an intensive care nurse at @NorthwellHealth this morning. https://t.co/wbyIo6GtI7